Regulatory

Part:BBa_K364304:Experience

Designed by: Endre Károly Kristóf   Group: iGEM10_Debrecen-Hungary   (2010-08-13)
Revision as of 15:04, 24 October 2010 by Lityupix (Talk | contribs) (→‎Applications of BBa_K364304)

(diff) ↠Older revision | Latest revision (diff) | Newer revision → (diff)

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K364304

The TRE-CMV construct can be used for switching on chosen genes by the addition of tetracyclin derivatives.

Resources

Juan L. Ramos, Manuel Martínez-Bueno, Antonio J. Molina-Henares, Wilson Terán, Kazuya Watanabe, Xiaodong Zhang, María Trinidad Gallegos, Richard Brennan, and Raquel Tobes. The TetR Family of Transcriptional Repressors. Microbiol Mol Biol Rev. 2005 June; 69(2): 326–356.

Jerome S Harms,corresponding author Kurt A Eakle, Lillian S Kuo, Robert D Bremel, and Gary A Splitter. Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells. Genet Vaccines Ther. 2004; 2: 11.

User Reviews

UNIQ24165fdb1a35e718-partinfo-00000000-QINU UNIQ24165fdb1a35e718-partinfo-00000001-QINU